Annual report pursuant to Section 13 and 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.7.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - Balance Sheets - USD ($)
Dec. 31, 2016
Dec. 31, 2015
Current Assets:    
Cash $ 225,379 $ 3,165
Escrow fund 79,855
Deferred contract software development costs - related party 55,938
Deposit on contract 75,000
Prepaid expenses and other current assets 119,545 3,000
Total current assets 499,779 62,103
Other Assets:    
Intangible assets, net
Property and equipment, net 38,735 42,297
Deposit 44,876
Total Assets 583,390 104,400
Current Liabilities:    
Accounts payable and accrued expenses 34,450 2,617
Unearned revenue - related party 156,000
Loans from officer 161,800
Total current liabilities 34,450 320,417
Long Term Liabilities:    
Convertible notes payable 25,000
Accrued interest 1,593
Derivative liability 4,392,075
Total long term liabilities 4,392,075 26,593
Total liabilities 4,426,525 347,010
Commitments and Contingencies
Mezzanine Equity    
Preferred Series A stock, par value $.01 per share, 134,000 shares authorized; 133,334 and 0 shares issued and outstanding at December 31, 2016 and 2015, respectively. Stated at redemption value. 1,500,004
Shareholders' Equity/(Deficit):    
Preferred Stock, par value $.01, 10,000,000 shares authorized all series [1] 210
Common stock, par value $.001 per share, 500,000,000 shares authorized; 44,520,065 and 41,400,000 shares issued and outstanding at December 31, 2016 and 2015, respectively 44,520 41,400
Additional paid-in capital (1,518,484) 208,600
Accumulated deficit (3,869,385) (492,610)
Total shareholders' equity/(deficit) (5,343,139) (242,610)
Total Liabilities and Shareholders' Equity/(Deficit) $ 583,390 $ 104,400
[1] Preferred Series A-1 stock, par value $.01 per share, 21,000 shares authorized; 20,371 and 0 shares issued and outstanding at December 31, 2016 and 2015, respectively; Preferred Series B stock, par value $.01 per share, 300,000 shares authorized; no shares issued and outstanding at December 31, 2016 and 2015, respectively; Series C stock, par value $.01 per share, 615 and 0 shares issued and outstanding at December 31, 2016 and 2015, respectively